Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS

Objective: Information on the cognitive complications of HIV/AIDS from sub-Saharan Africa, where statistics on HIV is alarming, is sparse because of lack of validated cognitive tools. This study assessed the usefulness and predictive validity of the HIV Dementia Scale (HDS) as a screening tool among...

Full description

Bibliographic Details
Main Authors: Olubunmi A Ogunrin, Emeka U Eze, Francis Alika
Format: Article
Language:English
Published: AOSIS 2009-11-01
Series:Southern African Journal of HIV Medicine
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/274
id doaj-6a7a704a107f4ee9ad862a2a3a7580d5
record_format Article
spelling doaj-6a7a704a107f4ee9ad862a2a3a7580d52020-11-25T00:21:36ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512009-11-0110310.4102/sajhivmed.v10i3.274274Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDSOlubunmi A Ogunrin0Emeka U Eze1Francis Alika2University of BeninUniversity of BeninUniversity of Benin Teaching HospitalObjective: Information on the cognitive complications of HIV/AIDS from sub-Saharan Africa, where statistics on HIV is alarming, is sparse because of lack of validated cognitive tools. This study assessed the usefulness and predictive validity of the HIV Dementia Scale (HDS) as a screening tool among HIV-positive Nigerian Africans. Design: HIV-positive patients were randomly selected over a period of two months. Setting: The HIV/AIDS outpatient clinic of the University teaching hospital, Benin City, Nigeria. Subjects: Asymptomatic and symptomatic HIV-positive patients were compared with age, sex and level of education-matched controls. Outcome measures: Cognitive performances on the modified HIV Dementia scale. Results: The performances of 160 HIV-positive (comprising 80 asymptomatic and 80 symptomatic) subjects were compared with 80 age, sex and level of education-matched HIV-negative subjects on the HDS. The mean HDS scores (maximum =12) were 10.78±1.18 (comparison subjects), 8.85±1.38 (asymptomatic) and 5.2±1.13 (symptomatic); phttps://sajhivmed.org.za/index.php/hivmed/article/view/274
collection DOAJ
language English
format Article
sources DOAJ
author Olubunmi A Ogunrin
Emeka U Eze
Francis Alika
spellingShingle Olubunmi A Ogunrin
Emeka U Eze
Francis Alika
Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
Southern African Journal of HIV Medicine
author_facet Olubunmi A Ogunrin
Emeka U Eze
Francis Alika
author_sort Olubunmi A Ogunrin
title Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
title_short Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
title_full Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
title_fullStr Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
title_full_unstemmed Usefulness of the HIV Dementia Scale in Nigerian patients with HIV/AIDS
title_sort usefulness of the hiv dementia scale in nigerian patients with hiv/aids
publisher AOSIS
series Southern African Journal of HIV Medicine
issn 1608-9693
2078-6751
publishDate 2009-11-01
description Objective: Information on the cognitive complications of HIV/AIDS from sub-Saharan Africa, where statistics on HIV is alarming, is sparse because of lack of validated cognitive tools. This study assessed the usefulness and predictive validity of the HIV Dementia Scale (HDS) as a screening tool among HIV-positive Nigerian Africans. Design: HIV-positive patients were randomly selected over a period of two months. Setting: The HIV/AIDS outpatient clinic of the University teaching hospital, Benin City, Nigeria. Subjects: Asymptomatic and symptomatic HIV-positive patients were compared with age, sex and level of education-matched controls. Outcome measures: Cognitive performances on the modified HIV Dementia scale. Results: The performances of 160 HIV-positive (comprising 80 asymptomatic and 80 symptomatic) subjects were compared with 80 age, sex and level of education-matched HIV-negative subjects on the HDS. The mean HDS scores (maximum =12) were 10.78±1.18 (comparison subjects), 8.85±1.38 (asymptomatic) and 5.2±1.13 (symptomatic); p
url https://sajhivmed.org.za/index.php/hivmed/article/view/274
work_keys_str_mv AT olubunmiaogunrin usefulnessofthehivdementiascaleinnigerianpatientswithhivaids
AT emekaueze usefulnessofthehivdementiascaleinnigerianpatientswithhivaids
AT francisalika usefulnessofthehivdementiascaleinnigerianpatientswithhivaids
_version_ 1725361919106220032